Publications by authors named "Jennie Taylor"

Claim this Profile
E
Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.
Ogechukwu A Asogwa, Linda Dirven, Tobias Walbert, Terri S Armstrong, David Arons, Jennie W Taylor

Neuro Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and imaging PHGDH-driven intrinsic resistance to mutant IDH inhibition in gliomas.
Céline Taglang, Georgios Batsios, Anne Marie Gillespie, Joanna J Phillips, Jennie W Taylor

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.
Geno Guerra, George Wendt, Lucie McCoy, Helen M Hansen, Linda Kachuri, Jennie W Taylor

Neuro Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatial synaptic connectivity underlies oligodendroglioma evolution and recurrence.
David Raleigh, Kanish Mirchia, Sena Oten, Thiebaud Picart, Minh Nguyen, Jennie Taylor

Res Sq· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I study of convection-enhanced delivery (CED) of liposomal-irinotecan using real-time magnetic resonance imaging in patients with recurrent high-grade glioma.
Kazim H Narsinh, Karishma Kumar, Krystof Bankiewicz, Alastair J Martin, Mitchell Berger, Jennie Taylor

J Neurooncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioma mutational signatures associated with haloalkane exposure are enriched in firefighters.
Vincent L Cannataro, Paige M Bracci, Jennie W Taylor, Lucie McCoy, Terri Rice

Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 underlies microenvironment immunosuppression and resistance to therapy in glioblastoma.
Jacob S Young, Nam Woo Cho, Calixto-Hope G Lucas, Hinda Najem, Kanish Mirchia, Jennie W Taylor

bioRxiv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Who will benefit from vorasidenib? Review of data from the literature and open questions.
Amélie Darlix, Matthias Preusser, Shawn L Hervey-Jumper, Helen A Shih, Emmanuel Mandonnet, Jennie W Taylor

Neurooncol Pract· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responses.
Calixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, Rohit Gupta, Ramin A Morshed, Jennie W Taylor

Neuro Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal profiling of IDH-mutant astrocytomas reveals acquired RAS-MAPK pathway mutations associated with inferior survival.
Eduardo Rodriguez Almaraz, Geno A Guerra, Nadeem N Al-Adli, Jacob S Young, Abraham Dada, Jennie W Taylor

Neurooncol Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.
Geno Guerra, George Wendt, Lucie McCoy, Helen M Hansen, Linda Kachuri, Jennie W Taylor

medRxiv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Life…Gets Turned Upside-Down…" Opportunities to Improve Palliative Care for High-Grade Glioma.
Rita C Crooms, Jeannys F Nnemnbeng, Jennie W Taylor, Nathan E Goldstein, Barbara G Vickrey

J Pain Symptom Manage· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinician perspectives on integrating neuro-oncology and palliative care for patients with high-grade glioma.
Rita C Crooms, Jeannys F Nnemnbeng, Jennie W Taylor, Nathan E Goldstein, Ksenia Gorbenko

Neurooncol Pract· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligodendroglioma patient survival is associated with circulating B-cells and age.
Jennie W Taylor, Gayathri Warrier, Helen M Hansen, Lucie McCoy, Terri Rice

Neurooncol Adv· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study.
Jantine G Röttgering, Jennie W Taylor, Melissa Brie, Tracy Luks, Shawn L Hervey-Jumper

Neurooncol Pract· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.
Surabhi Ranjan, Denise Leung, Ashley P Ghiaseddin, Jennie W Taylor, Mina Lobbous

Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Automatic Brain Tissue and Lesion Segmentation and Multi-Parametric Mapping of Contrast-Enhancing Gliomas without the Injection of Contrast Agents: A Preliminary Study.
Jing Liu, Angela Jakary, Javier E Villanueva-Meyer, Nicholas A Butowski, David Saloner, Jennie W Taylor

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combinatory vaccine with IMA950 plus varlilumab promotes effector memory T-cell differentiation in the peripheral blood of patients with low-grade gliomas.
Atsuro Saijo, Hirokazu Ogino, Nicholas A Butowski, Meghan R Tedesco, David Gibson, Jennie W Taylor

Neuro Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Ingo K Mellinghoff, Min Lu, Patrick Y Wen, Jennie W Taylor, Elizabeth A Maher

Nat Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Sara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, Jennie W Taylor, Javier E Villanueva-Meyer

Acta Neuropathol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurologic Complications of Conventional Chemotherapy and Radiation Therapy.
Jennie W Taylor

Continuum (Minneap Minn)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cells.
J K Wiencke, Emily Nissen, Devin C Koestler, Stan J Tamaki, Courtney M Tamaki, Jennie W Taylor

Res Sq· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of promoter methylation in glioblastoma suggests nonlinear prognostic effect.
David Gibson, Akshay Ravi, Eduardo Rodriguez, Susan Chang, Nancy Oberheim Bush, Jennie Taylor

Neurooncol Adv· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuro-oncology is a team sport: Is it time we added lifestyle coaches?
Jennie W Taylor

Neurooncol Pract· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative care referral across the disease trajectory in high-grade glioma.
Rita C Crooms, Jennie W Taylor, Nathalie Jette, Rachelle Morgenstern, Parul Agarwal

J Neurooncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis